Authors: Abraham, Adams, Adams, Adams, Adams, Bandura, Borg, Brazier, Briggs, Brighton, Brooks, Brorsson, Buljina, Chung, Cima, Cooper, Curtis, de Jong, de la Mata Llord, Deighton, Dellhag, Dellhag, Dellhag, Dellhag, Dunn, Earnshaw, Egan, Ellis, Fess, Fiebig, Flatt, Flatt, Fuchs, Gollwitzer, Gollwitzer, Gullick, Hammond, Hammond, Hammond, Hammond, Hammond, Hammond, Hammond, Helliwell, Henderson, Hoch, Hoenig, Horsten, Hurkmans, Jenkinson, Jones, Kapandji, Kennedy, Kennedy, Kind, Kraemer, Lachin, Lamb, Lard, Law, Lemmey, Lineker, Lorig, Luqmani, Malcus-Johnson, Manca, Marcora, Massy-Westropp, Mathiowetz, McGuigan, McLaughlin, Meichenbaum, Michie, Moher, Moseley, Mugii, Norkin, Nurmohamed, Osborn, O’Brien, O’Brien, Parsons, Perneger, Rajbhandary, Ramsey, Rejeski, Rønningen, SARAH Trial Team, Adams, Shauver, Sheeran, Singh, Smith, Smith, Stern, Steultjens, Suarez-Almazor, Swardh, Symmons, Taleisnik, Underwood, Van den Ende, van der Giesen, Vliet Vlieland, Vliet Vlieland, Ware, Wehbé, Wessel, Westby, Willan, Williams, Yelin, Young
Published: January 1, 2015
The SARAH trial (ISRCTN 89936343) was a randomised controlled trial evaluating an optimised exercise programme for hands and upper limbs added to standard care in patients with rheumatoid arthritis. The study assessed clinical effectiveness and cost-effectiveness outcomes, with the intervention focusing on strengthening and stretching exercises specifically designed for RA patients. The trial was funded by the NIHR Health Technology Assessment programme and conducted with support from multiple NIHR research infrastructure organisations, indicating rigorous methodology and adequate sample size for detecting meaningful differences in hand function outcomes.
View Source →